Ansan
Ansan
Ansan, Gyeonggi-do, South Korea11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO) | Chronic Pruritus of Unknown Origin | Recruiting | Phase 3 | 2026-09-28 | NCT07700056 | |
| Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 2 | 2026-09-28 | NCT06947993 | |
| SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Recruiting | Phase 3 | 2026-09-15 | NCT07415252 | |
| Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension. | Chronic Disease, Chronic Spontaneous Urticaria, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Active, not recruiting | Phase 3 | 2026-08-19 | NCT06042478 | |
| A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia | Biliary Dyspepsia | Recruiting | Phase 4 | 2026-07-29 | NCT07016269 | |
| A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones). | Cholesterol Cholelithiasis | Recruiting | Phase 4 | 2026-07-29 | NCT07005752 | |
| Evaluation of an Electric Stimulator for Medical Use by Personal (LRTPM1) for Visual Function in Early to Intermediate Dry Age-Related Macular Degeneration | age-related macular degeneration | Not yet recruiting | Not applicable | 2026-07-13 | NCT07700147 | |
| A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants | Digestive System Diseases, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, colitis, colonic disorder, connective tissue disorder, digestive system disorder, gastroenteritis, immune system disorder, inflammatory bowel disease, intestinal disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, ulcerative colitis | Recruiting | Not stated | 2026-07-06 | NCT06246123 | |
| Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Active, not recruiting | Phase 2 | 2026-06-22 | NCT04137562 | |
| LEXURE for Post-Stroke Aphasia | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, aphasia, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, communication disorder, language disorder, nervous system disorder, speech disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-05-14 | NCT07570264 | |
| Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast fibrocystic disease, breast neoplasm, cystic fibrosis, hereditary disease, lung disorder, neoplasm, pancreas disorder, respiratory system disorder, skin disorder | Active, not recruiting | Not stated | 2025-05-15 | NCT04585074 |